Blood-device interaction

Michael J. Simmonds, Nobuo Watanabe, Deepika Nandakumar, Jarod Horobin

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Management of organ failure has improved in recent years in parallel with advancements in interventions, including organ transplant, although the shortage of donor organs remains the rate-limiting step. The advent of mechanical alternatives to biological organs is a burgeoning area available to clinicians in a variety of scenarios, including short-term procedures (e.g., cardiopulmonary bypass), longer and acute management (e.g., extracorporeal membrane oxygenation), and semi-to-permanent therapies (e.g., ventricular assist devices). A paradigm shift has recently effected a transition from "bridge" therapies toward destination therapies, with a resultant increase in clinical utilization. It is clear, however, that while mechanical circulatory and respiratory support devices can sustain life, damage to blood and its constituents, and/or activation of cellular processes, can negatively impact recovery and health. These adverse effects may be broadly related to blood exposure to high shear stress and/or interactions between biological and artificial materials. Only through advances in mechanical circulatory and respiratory support to minimize blood damage will complications be overcome and mechanical devices attain their true potential.

Original languageEnglish
Title of host publicationMechanical Circulatory and Respiratory Support
PublisherElsevier Inc.
Pages597-626
Number of pages30
ISBN (Electronic)9780128104927
ISBN (Print)9780128104910
DOIs
Publication statusPublished - 2017 Oct 13

Fingerprint

Blood
Biological organs
Transplants
Oxygenation
Shear stress
Chemical activation
Health
Membranes
Recovery

Keywords

  • Blood compatibility
  • Blood damage
  • Blood rheology
  • Erythrocytes
  • Platelets

ASJC Scopus subject areas

  • Engineering(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Simmonds, M. J., Watanabe, N., Nandakumar, D., & Horobin, J. (2017). Blood-device interaction. In Mechanical Circulatory and Respiratory Support (pp. 597-626). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-810491-0.00019-9

Blood-device interaction. / Simmonds, Michael J.; Watanabe, Nobuo; Nandakumar, Deepika; Horobin, Jarod.

Mechanical Circulatory and Respiratory Support. Elsevier Inc., 2017. p. 597-626.

Research output: Chapter in Book/Report/Conference proceedingChapter

Simmonds, MJ, Watanabe, N, Nandakumar, D & Horobin, J 2017, Blood-device interaction. in Mechanical Circulatory and Respiratory Support. Elsevier Inc., pp. 597-626. https://doi.org/10.1016/B978-0-12-810491-0.00019-9
Simmonds MJ, Watanabe N, Nandakumar D, Horobin J. Blood-device interaction. In Mechanical Circulatory and Respiratory Support. Elsevier Inc. 2017. p. 597-626 https://doi.org/10.1016/B978-0-12-810491-0.00019-9
Simmonds, Michael J. ; Watanabe, Nobuo ; Nandakumar, Deepika ; Horobin, Jarod. / Blood-device interaction. Mechanical Circulatory and Respiratory Support. Elsevier Inc., 2017. pp. 597-626
@inbook{1e50a914edf94473a4e4b93efdf57e80,
title = "Blood-device interaction",
abstract = "Management of organ failure has improved in recent years in parallel with advancements in interventions, including organ transplant, although the shortage of donor organs remains the rate-limiting step. The advent of mechanical alternatives to biological organs is a burgeoning area available to clinicians in a variety of scenarios, including short-term procedures (e.g., cardiopulmonary bypass), longer and acute management (e.g., extracorporeal membrane oxygenation), and semi-to-permanent therapies (e.g., ventricular assist devices). A paradigm shift has recently effected a transition from {"}bridge{"} therapies toward destination therapies, with a resultant increase in clinical utilization. It is clear, however, that while mechanical circulatory and respiratory support devices can sustain life, damage to blood and its constituents, and/or activation of cellular processes, can negatively impact recovery and health. These adverse effects may be broadly related to blood exposure to high shear stress and/or interactions between biological and artificial materials. Only through advances in mechanical circulatory and respiratory support to minimize blood damage will complications be overcome and mechanical devices attain their true potential.",
keywords = "Blood compatibility, Blood damage, Blood rheology, Erythrocytes, Platelets",
author = "Simmonds, {Michael J.} and Nobuo Watanabe and Deepika Nandakumar and Jarod Horobin",
year = "2017",
month = "10",
day = "13",
doi = "10.1016/B978-0-12-810491-0.00019-9",
language = "English",
isbn = "9780128104910",
pages = "597--626",
booktitle = "Mechanical Circulatory and Respiratory Support",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Blood-device interaction

AU - Simmonds, Michael J.

AU - Watanabe, Nobuo

AU - Nandakumar, Deepika

AU - Horobin, Jarod

PY - 2017/10/13

Y1 - 2017/10/13

N2 - Management of organ failure has improved in recent years in parallel with advancements in interventions, including organ transplant, although the shortage of donor organs remains the rate-limiting step. The advent of mechanical alternatives to biological organs is a burgeoning area available to clinicians in a variety of scenarios, including short-term procedures (e.g., cardiopulmonary bypass), longer and acute management (e.g., extracorporeal membrane oxygenation), and semi-to-permanent therapies (e.g., ventricular assist devices). A paradigm shift has recently effected a transition from "bridge" therapies toward destination therapies, with a resultant increase in clinical utilization. It is clear, however, that while mechanical circulatory and respiratory support devices can sustain life, damage to blood and its constituents, and/or activation of cellular processes, can negatively impact recovery and health. These adverse effects may be broadly related to blood exposure to high shear stress and/or interactions between biological and artificial materials. Only through advances in mechanical circulatory and respiratory support to minimize blood damage will complications be overcome and mechanical devices attain their true potential.

AB - Management of organ failure has improved in recent years in parallel with advancements in interventions, including organ transplant, although the shortage of donor organs remains the rate-limiting step. The advent of mechanical alternatives to biological organs is a burgeoning area available to clinicians in a variety of scenarios, including short-term procedures (e.g., cardiopulmonary bypass), longer and acute management (e.g., extracorporeal membrane oxygenation), and semi-to-permanent therapies (e.g., ventricular assist devices). A paradigm shift has recently effected a transition from "bridge" therapies toward destination therapies, with a resultant increase in clinical utilization. It is clear, however, that while mechanical circulatory and respiratory support devices can sustain life, damage to blood and its constituents, and/or activation of cellular processes, can negatively impact recovery and health. These adverse effects may be broadly related to blood exposure to high shear stress and/or interactions between biological and artificial materials. Only through advances in mechanical circulatory and respiratory support to minimize blood damage will complications be overcome and mechanical devices attain their true potential.

KW - Blood compatibility

KW - Blood damage

KW - Blood rheology

KW - Erythrocytes

KW - Platelets

UR - http://www.scopus.com/inward/record.url?scp=85053337389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053337389&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-810491-0.00019-9

DO - 10.1016/B978-0-12-810491-0.00019-9

M3 - Chapter

AN - SCOPUS:85053337389

SN - 9780128104910

SP - 597

EP - 626

BT - Mechanical Circulatory and Respiratory Support

PB - Elsevier Inc.

ER -